10.6084/m9.figshare.11974503.v2 Jennie H. Best Jennie H. Best Steven C. Vlad Steven C. Vlad Lenore Tominna Lenore Tominna Ibrahim Abbass Ibrahim Abbass Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic Adis Journals 2020 Biologic Persistence Real-world Rheumatoid arthritis Tocilizumab 2020-03-25 10:01:17 Figure https://adisjournals.figshare.com/articles/figure/Real-World_Persistence_of_Tocilizumab_Compared_With_Other_Subcutaneous_Biologic_Disease-Modifying_Antirheumatic_Drugs_Among_Patients_With_Rheumatoid_Arthritis_Switching_From_Another_Biologic/11974503 <p>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p> <p>© The authors, CC-BY-NC 2020.<b> </b></p>